Skip to main content

Clinical Trials Unit

The Clinical Research Unit (CRU) of the Institute of Human Virology (IHV) supports clinical trials for complex infectious diseases under the directorship of Dr. Shyamasundaran Kottilil.  The research unit focuses on the treatment and prevention of viral diseases such as hepatitis B, hepatitis C and HIV, but also completes research on healthy volunteers. 

The CRU is comprised of a multidisciplinary team of physicians, nurse coordinators, research/study coordinators, a regulatory specialist, a biostatistician, a pharmacist, a research laboratory supervisor and a phlebotomist who help organize and implement the clinical trials.  The CRU conducts sponsored research studies as well as various investigator-initiated studies. 

Open Clinical Trials >

Why Enroll in a Clinical Trial?

  • Clinical trials test new treatments for HIV, hepatitis B, hepatitis C and other viral diseases.
  • During the trial you will be closely monitored by qualified health care professionals.
  • You will receive compensation for your time and effort.
  • Your participation can be a valuable contribution to future research and the treatment of people with HIV, hepatitis B, hepatitis C and other viral diseases.

IHV Clinical Trials Unit

Institute of Human Virology
725 W. Lombard Street
Baltimore, MD 21201

Directions to IHV Patient Parking

To enroll in a study call 410-706-1684.


The ASCEND Documentary: Patients, Providers, and Hepatitis C

An inside view of Hepatitis C treatment in an urban community health care setting.

Open Clinical Trials


Shyam Kottilil, MBBS, PhD

Shyam Kottilil, MBBS, PhD
Director, Clinical Research Unit (CRU)
Professor of Medicine